STRS Ohio’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-500
| Closed | -$12K | – | 2034 |
|
2022
Q2 | $12K | Sell |
500
-8,000
| -94% | -$192K | ﹤0.01% | 1988 |
|
2022
Q1 | $329K | Sell |
8,500
-4,000
| -32% | -$155K | ﹤0.01% | 1573 |
|
2021
Q4 | $731K | Sell |
12,500
-5,300
| -30% | -$310K | ﹤0.01% | 1331 |
|
2021
Q3 | $1.06M | Hold |
17,800
| – | – | ﹤0.01% | 1069 |
|
2021
Q2 | $1.54M | Buy |
17,800
+2,000
| +13% | +$173K | 0.01% | 885 |
|
2021
Q1 | $1.3M | Buy |
15,800
+4,800
| +44% | +$396K | ﹤0.01% | 990 |
|
2020
Q4 | $1M | Buy |
11,000
+5,800
| +112% | +$527K | ﹤0.01% | 1059 |
|
2020
Q3 | $207K | Buy |
5,200
+2,500
| +93% | +$99.5K | ﹤0.01% | 1657 |
|
2020
Q2 | $92K | Buy |
+2,700
| New | +$92K | ﹤0.01% | 1808 |
|
2020
Q1 | – | Sell |
-80,000
| Closed | -$1.57M | – | 2044 |
|
2019
Q4 | $1.57M | Hold |
80,000
| – | – | 0.01% | 712 |
|
2019
Q3 | $1.24M | Hold |
80,000
| – | – | 0.01% | 742 |
|
2019
Q2 | $1.62M | Hold |
80,000
| – | – | 0.01% | 687 |
|
2019
Q1 | $1.41M | Hold |
80,000
| – | – | 0.01% | 726 |
|
2018
Q4 | $1.03M | Sell |
80,000
-1,200
| -1% | -$15.4K | 0.01% | 775 |
|
2018
Q3 | $1.32M | Hold |
81,200
| – | – | 0.01% | 763 |
|
2018
Q2 | $920K | Buy |
81,200
+70,100
| +632% | +$794K | ﹤0.01% | 938 |
|
2018
Q1 | $108K | Hold |
11,100
| – | – | ﹤0.01% | 1588 |
|
2017
Q4 | $67K | Hold |
11,100
| – | – | ﹤0.01% | 1697 |
|
2017
Q3 | $43K | Hold |
11,100
| – | – | ﹤0.01% | 1805 |
|
2017
Q2 | $35K | Buy |
+11,100
| New | +$35K | ﹤0.01% | 1843 |
|